Olivier Salvado
Olivier Salvado
CSIRO Data61 - Head of Imaging and Computer Vision
Verified email at csiro.au - Homepage
Title
Cited by
Cited by
Year
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ...
The Lancet Neurology 12 (4), 357-367, 2013
14132013
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
CC Rowe, KA Ellis, M Rimajova, P Bourgeat, KE Pike, G Jones, J Fripp, ...
Neurobiology of aging 31 (8), 1275-1283, 2010
9242010
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
VL Villemagne, KE Pike, G Chételat, KA Ellis, RS Mulligan, P Bourgeat, ...
Annals of neurology 69 (1), 181-192, 2011
7732011
Relationship between atrophy and β‐amyloid deposition in Alzheimer disease
G Chételat, VL Villemagne, P Bourgeat, KE Pike, G Jones, D Ames, ...
Annals of neurology 67 (3), 317-324, 2010
3692010
Apparent fibre density: a novel measure for the analysis of diffusion-weighted magnetic resonance images
D Raffelt, JD Tournier, S Rose, GR Ridgway, R Henderson, S Crozier, ...
Neuroimage 59 (4), 3976-3994, 2012
3562012
An atlas-based electron density mapping method for magnetic resonance imaging (MRI)-alone treatment planning and adaptive MRI-based prostate radiation therapy
JA Dowling, J Lambert, J Parker, O Salvado, J Fripp, A Capp, C Wratten, ...
International Journal of Radiation Oncology* Biology* Physics 83 (1), e5-e11, 2012
2812012
β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia
P Bourgeat, G Chetelat, VL Villemagne, J Fripp, P Raniga, K Pike, ...
Neurology 74 (2), 121-127, 2010
2322010
Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective …
VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ...
Lancet Neurol 12 (4), 357-367, 2013
2212013
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study
N Villain, G Chételat, B Grassiot, P Bourgeat, G Jones, KA Ellis, D Ames, ...
Brain 135 (7), 2126-2139, 2012
2122012
Retinal vascular biomarkers for early detection and monitoring of Alzheimer’s disease
S Frost, Y Kanagasingam, H Sohrabi, J Vignarajan, P Bourgeat, ...
Translational psychiatry 3 (2), e233-e233, 2013
1942013
Predicting Alzheimer disease with β‐amyloid imaging: Results from the Australian imaging, biomarkers, and lifestyle study of ageing
CC Rowe, P Bourgeat, KA Ellis, B Brown, YY Lim, R Mulligan, G Jones, ...
Annals of neurology 74 (6), 905-913, 2013
1802013
Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease
V Doré, VL Villemagne, P Bourgeat, J Fripp, O Acosta, G Chetélat, L Zhou, ...
JAMA neurology 70 (7), 903-911, 2013
1622013
MRI-guided prostate radiation therapy planning: Investigation of dosimetric accuracy of MRI-based dose planning
J Lambert, PB Greer, F Menk, J Patterson, J Parker, K Dahl, S Gupta, ...
Radiotherapy and Oncology 98 (3), 330-334, 2011
1522011
Symmetric diffeomorphic registration of fibre orientation distributions
D Raffelt, JD Tournier, J Fripp, S Crozier, A Connelly, O Salvado
NeuroImage 56 (3), 1171-1180, 2011
1502011
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a …
SC Burnham, P Bourgeat, V Doré, G Savage, B Brown, S Laws, P Maruff, ...
The Lancet Neurology 15 (10), 1044-1053, 2016
1462016
Larger temporal volume in elderly with high versus low beta-amyloid deposition
G Chetelat, VL Villemagne, KE Pike, JC Baron, P Bourgeat, G Jones, ...
Brain 133 (11), 3349-3358, 2010
1312010
Larger temporal volume in asymptomatic elderly with high versus low beta-amyloid deposition
G Chetelat, V Villemagne, K Pike, JC Baron, P Bourgeat, G Jones, K Ellis, ...
Alzheimer's & Dementia: The Journal of the Alzheimer's Association 6 (4), S2-S3, 2010
131*2010
Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline
S Ayton, A Fazlollahi, P Bourgeat, P Raniga, A Ng, YY Lim, I Diouf, ...
Brain 140 (8), 2112-2119, 2017
1222017
Incidence of cerebral microbleeds in preclinical Alzheimer disease
PA Yates, PM Desmond, PM Phal, C Steward, C Szoeke, O Salvado, ...
Neurology 82 (14), 1266-1273, 2014
1152014
Lesion segmentation from multimodal MRI using random forest following ischemic stroke
J Mitra, P Bourgeat, J Fripp, S Ghose, S Rose, O Salvado, A Connelly, ...
NeuroImage 98, 324-335, 2014
1092014
The system can't perform the operation now. Try again later.
Articles 1–20